Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,840 | 10,806 | 12,367 | 13,628 | 2,526 |
| Marketable Securities | 27,146 | 23,271 | 24,128 | 24,347 | 37,691 |
| Receivables | 830 | 149 | 443 | 601 | 1,254 |
| Inventories | 50 | 182 | 103 | 103 | 81 |
| Other current assets | 268 | 132 | 227 | 316 | 159 |
| TOTAL | $41,134 | $34,540 | $37,268 | $38,995 | $41,711 |
| Non-Current Assets | |||||
| PPE Net | 12,615 | 12,550 | 12,472 | 12,406 | 12,266 |
| Other Non-Current Assets | 196 | 0 | 195 | 146 | 145 |
| TOTAL | $12,811 | $12,550 | $12,667 | $12,552 | $12,411 |
| Total Assets | $47,454 | $41,066 | $44,003 | $45,890 | $48,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 441 | 0 | 438 | 342 | 557 |
| Accrued Expenses | 997 | N/A | 505 | 503 | 638 |
| TOTAL | $1,488 | $934 | $1,073 | $975 | $1,325 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,488 | $41,066 | $1,073 | $975 | $1,325 |
| Shareholders' Equity | |||||
| Common Shares | 67 | N/A | 68 | 68 | 68 |
| Retained earnings | -2,401 | N/A | -4,190 | -1,326 | 1,112 |
| Other shareholders' equity | 3,684 | 0 | 1,870 | 969 | 1,046 |
| TOTAL | $45,966 | $N/A | $42,930 | $44,915 | $47,390 |
| Total Liabilities And Equity | $47,454 | $41,066 | $44,003 | $45,890 | $48,715 |